Danaher Corporation (DHR) Holdings Held by REDW Stanley Financial Advisors LLC
REDW Stanley Financial Advisors LLC held its position in shares of Danaher Corporation (NYSE:DHR) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,190 shares of the conglomerate’s stock at the end of the 2nd quarter. REDW Stanley Financial Advisors LLC’s holdings in Danaher Corporation were worth $269,000 at the end of the most recent quarter.
Other large investors have also bought and sold shares of the company. Peddock Capital Advisors LLC boosted its stake in Danaher Corporation by 17.4% during the first quarter. Peddock Capital Advisors LLC now owns 1,224 shares of the conglomerate’s stock worth $105,000 after acquiring an additional 181 shares in the last quarter. Proficio Capital Partners LLC boosted its stake in Danaher Corporation by 92.3% during the first quarter. Proficio Capital Partners LLC now owns 1,246 shares of the conglomerate’s stock worth $105,000 after acquiring an additional 598 shares in the last quarter. ClariVest Asset Management LLC bought a new stake in Danaher Corporation during the first quarter worth about $157,000. Cornerstone Advisors Inc. boosted its stake in Danaher Corporation by 62.0% during the second quarter. Cornerstone Advisors Inc. now owns 2,111 shares of the conglomerate’s stock worth $178,000 after acquiring an additional 808 shares in the last quarter. Finally, Baystate Wealth Management LLC boosted its stake in Danaher Corporation by 11.3% during the second quarter. Baystate Wealth Management LLC now owns 2,115 shares of the conglomerate’s stock worth $181,000 after acquiring an additional 215 shares in the last quarter. 75.75% of the stock is currently owned by institutional investors and hedge funds.
Several equities research analysts recently commented on the stock. Wells Fargo & Company reissued a “market perform” rating on shares of Danaher Corporation in a research note on Saturday, July 22nd. Jefferies Group LLC reissued a “buy” rating and set a $95.00 price objective on shares of Danaher Corporation in a research note on Friday, August 4th. BidaskClub lowered shares of Danaher Corporation from a “hold” rating to a “sell” rating in a research note on Tuesday, July 25th. Credit Suisse Group reissued a “buy” rating and set a $93.00 price objective on shares of Danaher Corporation in a research note on Wednesday, May 24th. Finally, Janney Montgomery Scott lowered shares of Danaher Corporation from a “buy” rating to a “neutral” rating in a research note on Wednesday, June 7th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and an average price target of $92.72.
TRADEMARK VIOLATION WARNING: This news story was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this news story on another domain, it was illegally copied and republished in violation of U.S. & international trademark and copyright law. The legal version of this news story can be accessed at https://www.thecerbatgem.com/2017/09/14/danaher-corporation-dhr-holdings-held-by-redw-stanley-financial-advisors-llc.html.
In other news, Director Linda P. Hefner sold 10,578 shares of the firm’s stock in a transaction dated Friday, July 21st. The shares were sold at an average price of $83.03, for a total value of $878,291.34. Following the sale, the director now directly owns 42,151 shares in the company, valued at approximately $3,499,797.53. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider William King sold 7,458 shares of the firm’s stock in a transaction dated Friday, July 21st. The shares were sold at an average price of $82.97, for a total transaction of $618,790.26. Following the completion of the sale, the insider now owns 18,245 shares in the company, valued at $1,513,787.65. The disclosure for this sale can be found here. Insiders sold a total of 71,496 shares of company stock worth $5,916,223 over the last 90 days. Company insiders own 12.20% of the company’s stock.
Danaher Corporation (DHR) opened at 87.24 on Thursday. Danaher Corporation has a 12-month low of $75.71 and a 12-month high of $88.01. The stock has a market capitalization of $60.60 billion, a PE ratio of 27.85 and a beta of 1.03. The stock’s 50 day moving average is $82.11 and its 200 day moving average is $84.15.
Danaher Corporation (NYSE:DHR) last released its quarterly earnings results on Thursday, July 20th. The conglomerate reported $0.99 earnings per share for the quarter, beating analysts’ consensus estimates of $0.97 by $0.02. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The business had revenue of $4.51 billion for the quarter, compared to analysts’ expectations of $4.50 billion. During the same period last year, the business earned $0.90 EPS. The company’s revenue was up 6.3% compared to the same quarter last year. Equities analysts anticipate that Danaher Corporation will post $3.95 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, September 29th will be issued a $0.14 dividend. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.64%. The ex-dividend date of this dividend is Thursday, September 28th. Danaher Corporation’s dividend payout ratio is currently 17.83%.
About Danaher Corporation
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Stock Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related stocks with our FREE daily email newsletter.